Inactive Instrument

Press Releases Zymergen Inc.

Equities

ZY

US98985X1000

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

Malaria Pipeline, Clinical Trials Studies, Emerging Drugs, Mergers and Acquisition, Licensing, Agreements & Collaborations, and Latest News 2023 (Updated)	Nov. 08	AQ
Korro Bio Appoints Dr. Steve Colletti as Chief Scientific Officer	23-03-01	AQ
Ginkgo Bioworks Provides Compensation Information Related to Recent Acquisitions	22-12-05	AQ
ZYMERGEN INC. : Completion of Acquisition or Disposition of Assets, Costs Associated with Exit or Disposal Activities, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modification to Rights of Security Holders, Changes in Control or Registrant, Change in Directors or Principal Officers, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Other Events, Financial Statements and Exhibits (form 8-K)	22-10-19	AQ
Ginkgo Bioworks Completes Acquisition of Zymergen	22-10-19	PR
ZYMERGEN INC. : Submission of Matters to a Vote of Security Holders (form 8-K)	22-10-18	AQ
Zymergen : Voting Agreement - Form 8-K	22-10-12	PU
ZYMERGEN INC. : Other Events (form 8-K)	22-10-12	AQ
Malaria Pipeline Landscape Analysis of 15+ Companies by DelveInsight	22-10-12	AQ
ZYMERGEN INC. : Costs Associated with Exit or Disposal Activities, Change in Directors or Principal Officers (form 8-K)	22-08-25	AQ
ZYMERGEN INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Zymergen - ZY	22-08-24	BU
ZYMERGEN INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)	22-08-15	AQ
ZYMERGEN INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Zymergen - ZY	22-07-25	BU
ZY Alert: Monsey Firm of Wohl & Fruchter LLP Investigating Sale of Zymergen to Ginkgo Bioworks	22-07-25	AQ
Zymergen : Ginkgo to Acquire Zymergen - Form 8-K	22-07-25	PU
ZYMERGEN INC. : Entry into a Material Definitive Agreement, Costs Associated with Exit or Disposal Activities, Change in Directors or Principal Officers, Other Events, Financial Statements and Exhibits (form 8-K)	22-07-25	AQ
Zymergen Expands Agreement with Octant to Scale Next-Generation Drug Discovery Platform	22-07-14	AQ
Zymergen Announces R&D Supply Agreement with 3D4Makers to Provide New Polyimide for Use in High-Performance 3D Printing Applications	22-06-28	AQ
ZYMERGEN INC. : Submission of Matters to a Vote of Security Holders (form 8-K)	22-06-03	AQ
Zymergen Sells Modular Automation System to Octant to Scale Next-Generation Drug Discovery Platform	22-05-26	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Zymergen Inc.

Equities

ZY

US98985X1000

Press Releases

Filters